KLK3 and cancer: Measurement of KLK3 protein and KLK3 mRNA levels showed that the ability of serum to induce KLK3 production in cancer cells was proportional to serum progesterone levels, with the greatest stimulation occurring with serum containing more progesterone (days 22–24 of the menstrual cycle).